A world first for machine learning in medicine: AI designed drug heads for human trials

via Pioneering Minds

A drug molecule “invented” by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine.

It was created by British start-up Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma.

The drug will be used to treat patients who have obsessive-compulsive disorder (OCD).

Typically, drug development takes about five years to get to trial, but the AI drug took just 12 months.

Exscienta chief executive Prof Andrew Hopkins described it as a “key milestone in drug discovery”.

He told the BBC: “We have seen AI for diagnosing patients and for analysing patient data and scans, but this is a direct use of AI in the creation of a new medicine.”

Learn more: Artificial intelligence-created medicine to be used on humans for first time

Go deeper with Bing News on:

AI designed drug

How AI trained to beat Atari games could impact robotics and drug design
on March 5, 2021 at 12:24 am
Uber and OpenAI researchers say an advance in Go-Explore AI in beating Atari games could have applications for robotics and drug design.
Chinese firm Insilico to test AI-developed drug
on March 4, 2021 at 10:49 pm
Photo/IC] Insilico Medicine, a Chinese investors-backed company that uses artificial intelligence to develop new drugs, said that its chemical compound candidate is likely to ent ...
AI and Alzheimer's Disease
on March 4, 2021 at 2:50 pm
New treatments for Alzheimer’s disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options. Now, a team at Harvard Medical School ...
AI-based method for repurposing existing drugs into potential treatments for Alzheimer's
on March 4, 2021 at 8:49 am
New treatments for Alzheimer's disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options.
Engaging AI in the battle against Alzheimer’s
on March 4, 2021 at 4:23 am
A team of researchers has developed an artificial intelligence-based method to screen currently available medications as possible treatments for Alzheimer’s disease. The method could represent a rapid ...

Go deeper with Google Headlines on:

AI designed drug

Exscientia Secures $100M To Expand AI Drug Discovery Platform - - HIT Consultant
March 4, 2021
Fund management giant BlackRock backs $100m injection into UK drug developer Exscientia - Sky News
March 3, 2021
Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI - PR Newswire India
February 24, 2021
Chinese firm Insilico to test AI-developed drug - Chinadaily USA
March 5, 2021
Pfizer the latest pharma to befriend Iktos for its AI drug discovery platform - FierceBiotech
March 2, 2021

Go deeper with Bing News on:

Machine learning in medicine

High-dimensional hepatopath data analysis by machine learning for predicting HBV-related fibrosis
on March 2, 2021 at 4:00 pm
Machine learning algorithms are particularly adept at analyzing medical phenomenon by capturing complex and nonlinear relationships in clinical data. Our study proposed a predictive model on the basis ...
Machine Learning Shows Social Media Greatly Affects COVID-19 Beliefs
on March 2, 2021 at 10:05 am
Machine learning tools analyzed tweets about COVID-19 and showed that social media can significantly influence people's health beliefs.
An open-source machine learning framework to carry out systematic reviews
on March 2, 2021 at 9:44 am
When scientists carry out research on a given topic, they often start by reviewing previous study findings. Conducting systematic literature reviews or meta-analyses can be very challenging and time ...
Code-free deep learning for multi-modality medical image classification
on March 1, 2021 at 8:38 am
Several technology companies offer platforms for users without coding experience to develop deep learning algorithms. This Analysis compares the performance of six ‘code-free deep learning’ platforms ...
MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
on February 26, 2021 at 11:03 am
Inc. (NEO: MMED, OTCQB: MMEDF, DE: MMQ) ("MindMed"), a leading psychedelic medicine biotech company, is pleased to announce that it has closed the previously announced acquisition of HealthMode, a ...